https://www.otplinks.comhttps://www.voafit.com/otpEpisode Referenced: https://www.youtube.com/watch?v=K8kaSoFCZ0c&amp;t=41sThe retatrutide biologic fight is bigger than folks understand.This breakdown covers the current situation surrounding the retatrutide discussion. If you have been following the narrative, this episode provides context on why this biologic fight is garnering a lot of attention, and more importantly why it matters to every person watching this space. I first reported on these developments two years ago and offer insights gained from direct conversations with industry experts.We analyze the trajectory of this controversy to help you separate the signal from the noise. This episode serves as a vital update for anyone trying to track the retatrutide saga as it continues to evolve.Subscribe for weekly internet news breakdowns and let me know in the comments if you want more updates on this story as it develops.

Retatrutide Biologic Battle: The Story Gets Bigger

On The Pen GLP-1 News

If you've been listening to all the news about the Retatrutide and the biologic fight, and you think you have a handle on how this impacts you, you should probably listen to this podcast. This is a story we brought to you originally two years ago. We were the first on the internet talking about it. And since then, we've had ongoing dialogue with industry experts, people at the highest levels of compounding in pharma.

And we believe that we've got an angle on this that nobody else is talking about or has identified here. And I think that this is a very, very, very important conversation. If the future of obesity medicine or access to compounding any GLP-1 is important to you, this is a reason to stay tuned to this podcast. That's what we're going to get into on this episode of the Weekly Dose Podcast. Welcome back.

Welcome to the On The Pen Podcast with your host, Dave Knapp. Welcome back to the Weekly Dose Podcast. I'm your host, Dave Knapp, Man On The Mounjaro. That's why I'm here. You are on the pen.

We go be Saxenda, Victoza, Trulicity, Mounjaro, Zepbound, Compound, that pen. It's what we talk about each and every week on the podcast here. In fact, this is a top tier US medical podcast in the top 1% of all podcasts globally. So if you're new here because you just started a GLP-1 journey or if you just found our content for the first time, welcome.

We do more than just aggregating the news. Since 2022, we've been bringing you information that empowers you to have better conversations with your doctor because we know that that time you have to chat with your doctor is finite and you have to make the most...

Retatrutide Biologic Battle: The Story Gets Bigger

Read the full transcript

The candid version is on a podcast,
not the earnings call.

Retatrutide Biologic Battle: The Story Gets Bigger

Read the full transcript

The candid version is on a podcast, not the earnings call.

The candid version is on a podcast,
not the earnings call.